ORGANOGENESIS HOLDINGS INC. Shareholders' Equity
ORGANOGENESIS HOLDINGS INC. (ORGO) had Shareholders' Equity of $148.27 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $148.27M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $244.56M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $300.13M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $255.13M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $148.27M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $244.56M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $300.13M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $255.13M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $233.24M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $242.90M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $262.90M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $278.55M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $263.50M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $278.03M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $278.66M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $276.87M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $271.28M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $263.70M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $265.67M 10-K · filed 2026-02-26 | |
| 2022-09-30 | $256.33M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $254.38M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $241.53M 10-Q · filed 2023-08-09 | $243.23M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $241.34M 10-K · filed 2025-02-27 | $242.03M 10-K · filed 2022-03-01 |
| 2021-09-30 | $189.17M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $174.65M 10-Q · filed 2022-11-09 | $178.92M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $153.02M 10-Q · filed 2022-08-09 | $157.29M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $141.81M 10-K · filed 2024-02-29 | $146.08M 10-K · filed 2021-03-16 |
| 2020-09-30 | $61.38M 10-Q · filed 2021-11-09 | $65.47M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $31.83M 10-Q · filed 2021-11-09 | $35.75M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $40.30M 10-Q · filed 2021-08-09 | |
| 2019-12-31 | $52.02M 10-K · filed 2023-03-01 | $55.58M 10-K · filed 2020-03-09 |
| 2019-09-30 | $12.81M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $23.20M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $32.56M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $39.94M 10-K · filed 2022-03-01 | $47.04M 10-K · filed 2019-03-18 |
| 2018-09-30 | -$24.23M 10-Q · filed 2019-11-12 | $5.00M 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$57.17M 10-Q · filed 2019-11-12 | $5.00M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$37.44M 10-Q · filed 2019-08-09 | $5.00M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$15.32M 10-K · filed 2021-03-16 | $5.00M 10-K · filed 2018-03-14 |
| 2017-09-30 | $5.00M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $5.00M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $5.00M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$15.98M 10-K · filed 2020-03-09 | $5.00M 10-K · filed 2017-03-28 |
| 2016-09-30 | -$30.70K 10-Q · filed 2016-11-18 | |
| 2015-12-31 | $3.51M 10-K · filed 2019-03-18 | -$162.00 10-Q · filed 2016-11-18 |
| 2015-12-03 | $0.00 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |